tirzepatide gip mechanism Bumps and humps in the success of as the first GLP1 and receptor agonist Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability

The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust your workout routine when taking a GLP-1.

Mark Cuban is #694 on Forbes' 2026 Billionaires list

Injectable peptides like semaglutide were developed as diabetic medications but are now used for weight loss (Ozempic, Wegovy, Mounjaro)

Compounded drugs are not regulatory approved, despite having similar active ingredients

Semaglutide can be safely initiated with concomitant dexamfetamine (Adderall) without dose adjustments, but requires close monitoring for additive gastrointe...